RichardAColvinMDPhD

Chief Medical Officer

Dr. Colvin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
55 Fruit Street
Cox 5
Boston, MA 02114
Phone+1 617-726-3812

Fax+1 617-726-2894

Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Infectious Disease, 1999 - 2003
Brigham and Women's HospitalResidency, Internal Medicine, 1996 - 1999
Duke University School of MedicineClass of 1996

PubMed

232 citations
Mouse CCL8, a CCR8 agonist, promotes atopic dermatitis by recruiting IL-5 + T H 2 cells
Sabina A. Islam, Daniel S Chang, Richard A. Colvin, Michael H. Byrne, Michelle L. McCully
Nature Immunology. 2011-02-01
105 citations
CXCR3 requires tyrosine sulfation for ligand binding and a second extracellular loop arginine residue for ligand-induced chemotaxis.
Richard A. Colvin, Gabriele S. V. Campanella, Lindsay A. Manice, Andrew D. Luster
Molecular and Cellular Biology. 2006-08-01
153 citations
Adiponectin inhibits the production of CXC receptor 3 chemokine ligands in macrophages and reduces T-lymphocyte recruitment in atherogenesis.
Yoshihisa Okamoto, Eduardo J. Folco, Manabu Minami, Akm Khyrul Wara, Mark W. Feinberg
Circulation Research. 2008-02-01

Abstracts/Posters

Northstar-3: Interim Results from a Phase 3 Study Evaluating Lentiglobin Gene Therapy in Patients with Transfusion-Dependent _-Thalassemia and Either a _0 or IVS-I-110...
Richard A. Colvin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Northstar-2: Updated Safety and Efficacy Analysis of Lentiglobin Gene Therapy in Patients with Transfusion-Dependent _-Thalassemia and Non-_0/_0 Genotypes
Richard A. Colvin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Signaling Through Chemokine Receptor CXCR3National Institute Of Allergy And Infectious Diseases2001–2003